Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 30, Issue Suppl 3
408 Dose-dense paclitaxel and carboplatin plus bevacizumab is an effective and a tolerable first-line regimen for advanced ovarian cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Poster
IGCS20_1442
408 Dose-dense paclitaxel and carboplatin plus bevacizumab is an effective and a tolerable first-line regimen for advanced ovarian cancer
Free
Online download statistics by month:
Online download statistics by month: November 2020 to March 2024
Abstract
Full
Pdf
Nov 2020
26
0
8
Dec 2020
19
0
9
Jan 2021
16
0
4
Feb 2021
7
0
6
Mar 2021
14
0
3
Apr 2021
8
0
5
May 2021
3
0
2
Jun 2021
0
0
5
Jul 2021
0
0
4
Aug 2021
0
0
7
Sep 2021
0
0
2
Oct 2021
4
0
14
Nov 2021
11
0
14
Dec 2021
12
0
4
Jan 2022
16
0
4
Feb 2022
14
0
0
Mar 2022
12
0
1
Apr 2022
8
0
2
May 2022
18
0
9
Jun 2022
20
0
5
Jul 2022
24
0
0
Aug 2022
8
0
1
Sep 2022
12
0
7
Oct 2022
15
0
2
Nov 2022
16
0
5
Dec 2022
22
0
3
Jan 2023
6
0
1
Feb 2023
16
0
0
Mar 2023
17
0
2
Apr 2023
6
0
3
May 2023
20
0
1
Jun 2023
2
0
1
Jul 2023
10
0
4
Aug 2023
6
0
2
Sep 2023
6
0
3
Oct 2023
26
0
6
Nov 2023
24
0
4
Dec 2023
23
0
1
Jan 2024
6
0
1
Feb 2024
10
0
2
Mar 2024
8
0
24
Total
491
0
181
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?